Trade Mark Journal No.2025/050 12 December 2025

UK00004301806 27 November 2025 (5)

MAVACAMTEN BMS

Class 5: Pharmaceutical preparations for prevention and treatment of cardiovascular diseases and disorders.

Bristol-Myers Squibb Company

Representative: Sipara Limited